Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Lyra Therapeutics, Inc. | lyra-ex322_7.htm |
| EX-32.1 - EX-32.1 - Lyra Therapeutics, Inc. | lyra-ex321_6.htm |
| EX-31.2 - EX-31.2 - Lyra Therapeutics, Inc. | lyra-ex312_8.htm |
| EX-31.1 - EX-31.1 - Lyra Therapeutics, Inc. | lyra-ex311_9.htm |
| EX-4.4 - EX-4.4 - Lyra Therapeutics, Inc. | lyra-ex44_349.htm |
| 10-K - 10-K - Lyra Therapeutics, Inc. | lyra-10k_20201231.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Lyra Therapeutics, Inc.
Watertown, Massachusetts
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (333-237973) of Lyra Therapeutics, Inc. of our report dated March 9, 2021 relating to the consolidated financial statements, which appears in this Annual Report on Form 10-K.
/s/ BDO USA, LLP
Boston, Massachusetts
March 9, 2021